Allergan Sales, LLC et al v. Breckenridge Pharmaceutical, Inc.
| Allergan USA, Inc., Allergan Sales, LLC and Allergan Pharmaceuticals International Limited |
| Breckenridge Pharmaceutical, Inc. |
| 1:2020cv00199 |
| February 10, 2020 |
| US District Court for the District of Delaware |
| Mitchell S Goldberg |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on February 27, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 7 WAIVER OF SERVICE returned executed by Allergan Sales, LLC, Allergan Pharmaceuticals International Limited, Allergan USA, Inc.: For Breckenridge Pharmaceutical, Inc. waiver sent on 2/26/2020, answer due 4/27/2020. (Tigan, Jeremy) |
| Case Assigned to Judge Mitchell S. Goldberg of the U.S. District Court for the Eastern District of Pennsylvania. Please include the initials of the Judge (MSG) after the case number on all documents filed. (rjb) |
| Filing 6 SUMMONS Returned Executed by Allergan Sales, LLC, Allergan Pharmaceuticals International Limited, Allergan USA, Inc.. Breckenridge Pharmaceutical, Inc. served on 2/11/2020, answer due 3/3/2020. (Tigan, Jeremy) |
| Summons Issued with Magistrate Consent Notice attached as to Breckenridge Pharmaceutical, Inc. on 2/11/2020. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (myr) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Allergan plc for Allergan Pharmaceuticals International Limited, Allergan Sales, LLC, Allergan USA, Inc. filed by Allergan Pharmaceuticals International Limited, Allergan Sales, LLC, Allergan USA, Inc. (myr) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,763,476. (myr) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: December 30, 2019. Date of Expiration of Patent: June 9, 2020.Thirty Month Stay Deadline: 12/10/2020. (myr) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Breckenridge Pharmaceutical, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-2848958.) - filed by Allergan Sales, LLC, Allergan Pharmaceuticals International Limited, Allergan USA, Inc.. (Attachments: #1 Exhibit A-B, #2 Civil Cover Sheet)(myr) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
